Furthermore, heterozygous mutations in GBA1 are among the most important genetic risk factors for PD (13–16), contributing to a more rapid progression of motor and nonmotor symptoms (17–21), and they also appear to be important predictors for nonmotor symptom progression after deep brain stimulation surgery in patients with PD (18, 22). The gene discussed is GBA1; the disease is Parkinson disease.